WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of China-based WuXi AppTec, has announced a licensing agre...
BioDuro-Sundia, an industry-leading drug discovery, development and commercial service contract research development and...
The COVID-19 pandemic highlighted the successful development and utilisation of mRNA vaccines. This has encouraged bioph...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), has announced a ...
Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO), has signed a land pur...
TFBS Bioscience Inc., the leading GMP viral vector contract development and manufacturing organization in the Asia-Pacif...
GenScript ProBio, a global CDMO, and South Korea-based startup DAAN Bio Therapeutics, have entered into a strategic...
Amaran Biotechnology Inc., a subsidiary of Taiwan's OBI Pharma Inc., has completed the construction of it...
WuXi STA, a subsidiary of China-based WuXi AppTec, has announced the opening of a new large-scale oligonucleotide and pe...
Next milestone for the site development is achieved Positive feedback recei...
Japan-based Fujifilm Corporation has announced the investment of $1.6 billion to enhance and expand the cell culture man...
WuXi STA, a WuXi AppTec company, has opened another high-potency API (HPAPI) plant at its Changzhou site (Jiangsu, China...
Companies in the pharmaceutical sector have been facing fierce competition, cost pressure, technological innovations, an...
Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...
Merck has announced that its Life Science business sector has doubled its high-potent active pharmaceutical ingredients ...
WuXi Biologics, a global contract research, development and manufacturing organisation (CRDMO) service company, has succ...
South Korea-based Hanmi Fine Chemical, a subsidiary of Hanmi Pharmaceutical Group specializing in APIs (Active Pharmaceu...
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...